BTG3 Activators
BTG3 activators are a diverse group of chemical compounds that enhance the functional activity of BTG3, either directly or indirectly, through specific biochemical pathways or cellular processes that it is directly involved in. Forskolin, Isoprenaline, Epinephrine, Norepinephrine, L-DOPA (Levodopa), and Dibutyryl-cAMP are compounds that increase intracellular cAMP levels, thereby activating the PKA pathway. This activation leads to the phosphorylation of proteins involved in cellular homeostasis, indirectly enhancing the function of BTG3. Sodium Nitroprusside, another activator, generates nitric oxide, activating the cGMP pathway, which, similar to the PKA pathway, can lead to the phosphorylation of proteins involved in cellular homeostasis.
Histamine, Adenosine Triphosphate (ATP), and Acetylcholine are compounds that increase intracellular calcium levels. Calcium, being a known cofactor for numerous enzymes, can influence protein-protein interactions, thereby enhancing the functional activity of BTG3BTG3. Nifedipine, on the other hand, is an L-type calcium channel blocker that alters calcium-dependent processes, indirectly enhancing the function of BTG3.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is an adenylyl cyclase activator that increases intracellular cAMP levels. An increase in cAMP levels activates the PKA pathway, which subsequently phosphorylates and activates various proteins. This can enhance the functional activity of BTG3, which is involved in protein-protein interactions and is known to be regulated by phosphorylation. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine is a catecholamine that increases intracellular cAMP levels. The resultant activation of the PKA pathway could lead to phosphorylation and activation of various proteins, including BTG3, thereby enhancing its functionality. | ||||||
L-Noradrenaline | 51-41-2 | sc-357366 sc-357366A | 1 g 5 g | $326.00 $485.00 | 3 | |
Norepinephrine, a catecholamine, increases intracellular cAMP levels and activates the PKA pathway. The activation of this pathway leads to phosphorylation of proteins, indirectly enhancing the functional activity of BTG3. | ||||||
Levodopa | 59-92-7 | sc-205372 sc-205372A | 5 g 25 g | $54.00 $171.00 | 9 | |
L-DOPA, a precursor to catecholamines, can increase intracellular cAMP levels upon conversion. This leads to the activation of the PKA pathway, which induces phosphorylation of proteins, thereby enhancing the functionality of BTG3, which is known to be regulated by phosphorylation. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cell-permeable cAMP analog that activates the PKA pathway. This activation leads to the phosphorylation and activation of proteins, which can enhance the functional activity of BTG3 due to its role in protein-protein interactions and its regulation by phosphorylation. | ||||||
Sodium nitroprusside dihydrate | 13755-38-9 | sc-203395 sc-203395A sc-203395B | 1 g 5 g 100 g | $43.00 $85.00 $158.00 | 7 | |
Sodium Nitroprusside generates nitric oxide, which activates the cGMP pathway. This pathway can lead to the phosphorylation of proteins, including BTG3, enhancing its functional activity. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Histamine, via the H1 receptor, increases intracellular calcium levels. Calcium is a cofactor for numerous enzymes and can influence protein-protein interactions, enhancing the functional activity of BTG3. | ||||||
Adenosine 5′-Triphosphate, disodium salt | 987-65-5 | sc-202040 sc-202040A | 1 g 5 g | $39.00 $75.00 | 9 | |
ATP, when released into the extracellular space, can bind to P2X receptors, leading to an increase in intracellular calcium levels. This can enhance protein-protein interactions, indirectly enhancing the function of BTG3. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Nifedipine is an L-type calcium channel blocker. By reducing intracellular calcium concentrations, it alters calcium-dependent processes, indirectly enhancing the function of BTG3 by modulating the calcium-dependent pathways it may be involved in. | ||||||